| UniProt ID | NMNA1_HUMAN | |
|---|---|---|
| UniProt AC | Q9HAN9 | |
| Protein Name | Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 {ECO:0000305} | |
| Gene Name | NMNAT1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 279 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Catalyzes the formation of NAD(+) from nicotinamide mononucleotide (NMN) and ATP. [PubMed: 17402747 Can also use the deamidated form; nicotinic acid mononucleotide (NaMN) as substrate with the same efficiency] | |
| Protein Sequence | MENSEKTEVVLLACGSFNPITNMHLRLFELAKDYMNGTGRYTVVKGIISPVGDAYKKKGLIPAYHRVIMAELATKNSKWVEVDTWESLQKEWKETLKVLRHHQEKLEASDCDHQQNSPTLERPGRKRKWTETQDSSQKKSLEPKTKAVPKVKLLCGADLLESFAVPNLWKSEDITQIVANYGLICVTRAGNDAQKFIYESDVLWKHRSNIHVVNEWIANDISSTKIRRALRRGQSIRYLVPDLVQEYIEKHNLYSSESEDRNAGVILAPLQRNTAEAKT | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 7 | Phosphorylation | -MENSEKTEVVLLAC -CCCCCCCEEEEEEC | 29.93 | 24719451 | |
| 34 | Phosphorylation | LFELAKDYMNGTGRY HHHHHHHHHCCCCCE | 7.56 | 22210691 | |
| 41 | Phosphorylation | YMNGTGRYTVVKGII HHCCCCCEEEEEEEE | 12.77 | - | |
| 42 | Phosphorylation | MNGTGRYTVVKGIIS HCCCCCEEEEEEEEE | 19.91 | 22210691 | |
| 55 | Phosphorylation | ISPVGDAYKKKGLIP EECCCHHHHHCCCHH | 28.25 | - | |
| 64 | Phosphorylation | KKGLIPAYHRVIMAE HCCCHHHHHHHHHHH | 5.70 | - | |
| 90 | Ubiquitination | DTWESLQKEWKETLK CHHHHHHHHHHHHHH | 71.48 | - | |
| 109 | Phosphorylation | HQEKLEASDCDHQQN HHHHHHHHCCCCCCC | 29.42 | 29255136 | |
| 117 | Phosphorylation | DCDHQQNSPTLERPG CCCCCCCCCCCCCCC | 18.22 | 29255136 | |
| 119 | Phosphorylation | DHQQNSPTLERPGRK CCCCCCCCCCCCCCC | 40.86 | 30266825 | |
| 128 | Ubiquitination | ERPGRKRKWTETQDS CCCCCCCCCCCCCCC | 62.60 | - | |
| 130 | Phosphorylation | PGRKRKWTETQDSSQ CCCCCCCCCCCCCHH | 31.99 | 28985074 | |
| 135 | Phosphorylation | KWTETQDSSQKKSLE CCCCCCCCHHHHCCC | 25.50 | 21815630 | |
| 136 | Phosphorylation | WTETQDSSQKKSLEP CCCCCCCHHHHCCCC | 55.07 | 25159151 | |
| 208 | Phosphorylation | DVLWKHRSNIHVVNE HCEEECCCCEEECCH | 39.60 | 17322306 | |
| 222 | Phosphorylation | EWIANDISSTKIRRA HHHHHCCCHHHHHHH | 34.51 | 27251275 | |
| 223 | Phosphorylation | WIANDISSTKIRRAL HHHHCCCHHHHHHHH | 33.77 | 27251275 | |
| 250 | Ubiquitination | LVQEYIEKHNLYSSE HHHHHHHHCCCCCCC | 28.38 | - | |
| 261 | Methylation | YSSESEDRNAGVILA CCCCCCCCCCCEEEE | 30.74 | 115485213 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 136 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NMNA1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NMNA1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| NTRK2_HUMAN | NTRK2 | physical | 21988832 | |
| SIK1_HUMAN | SIK1 | physical | 21988832 | |
| NMNA1_HUMAN | NMNAT1 | physical | 25416956 | |
| SIR1_HUMAN | SIRT1 | physical | 19478080 | |
| PCY1A_HUMAN | PCYT1A | physical | 26186194 | |
| CDC5L_HUMAN | CDC5L | physical | 26186194 | |
| NMNA1_HUMAN | NMNAT1 | physical | 21516116 | |
| PCY1A_HUMAN | PCYT1A | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 608553 | Leber congenital amaurosis 9 (LCA9) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-117, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-119, AND MASSSPECTROMETRY. | |